The Associations of Gender, Menopause, Age, and Asthma with REM-Predominant Obstructive Sleep Apnea: A Prospective Observational Study.

PURPOSE: The study sought to assess demographics, clinical features, comorbidities, and polysomnographic features of a large cohort of clinic-based patients with rapid eye movement-predominant obstructive sleep apnea (REM-predominant-OSA) in both genders, while assessing the relationship between REM-predominant OSA in one hand and menopausal status and age on the other.
METHODS: This prospective observational study was conducted between January 2003 and December 2017. REM-predominant OSA diagnostic criteria included an AHI of ≥5/h, with REM-AHI/non-REM-AHI of >2, a non-REM-AHI of <15/h, and a minimum of 15 min of REM sleep. Patients who had an AHI>5 events/h and did not meet the criteria for REM-predominant OSA were included in the non-stage-specific OSA group (NSS).
RESULTS: The study consisted of 1346 men and 823 women (total=2169). REM-predominant OSA was diagnosed in 17% (n=369). The prevalence of REM-predominant OSA in women was 25% compared with 12% in men. Several independent associations of REM-predominant OSA were identified in the whole group, including age (OR: 0.97 [0.95-0.98], p<0.01), female sex (OR: 6.95 [4.86-9.93], p>0.01), REM sleep duration (min) (OR: 1.02 [1.02-1.03], < 0.01), and time with SpO2 <90% (mins) (OR: 0.97 [0.95-0.99], < 0.01), hypertension (OR:0.67 [0.45-0.99], 0.04) and asthma (OR: 2.19 [1.56-3.07], < 0.01). The prevalence of REM-predominant OSA in premenopausal and postmenopausal women was 35% and 18.6% (p< 0.01), respectively. Among women, age was an independent correlate (OR: 0.97 [0.94-0.99], p=0.03; however, menopausal status was not.
CONCLUSION: REM-predominant OSA is prevalent among clinic-based patients with OSA. A younger age and female sex were independent correlates of REM-predominant OSA. Among women, a younger age but not menopausal status was a correlate of REM-predominant OSA. Asthma was independently associated with REM-predominant OSA.

Introduction

Obstructive sleep apnea (OSA) is a common sleep disorder that occurs during sleep and causes repetitive cessation of the upper airway and intermittent hypoxemia. The overall population-prevalence of OSA ranges from 9% to 38% and is higher among men.1 It is estimated that approximately 1 billion middle-aged adults worldwide could have OSA, and the estimated number of middle-aged adults with moderate to severe OSA, for which treatment is generally recommended, is nearly 425 million.2

Upper airway narrowing can occur during rapid eye movement (REM) and non-REM (NREM) sleep. In REM sleep, pharyngeal muscle activity decreases and significantly increases the inclination for upper airway collapse due to the removal of excitatory noradrenergic and serotonergic inputs to upper airway motor neurons.3 Therefore, REM sleep in some patients with OSA is characteristically accompanied by an increased incidence of obstructive events, that are frequently prolonged and followed with severe oxygen desaturation.4 REM-related OSA is used loosely by sleep clinicians when polysomnography (PSG) shows obstructive sleep-disordered breathing events that occur predominantly or exclusively in REM sleep.5 A common criterion used for diagnosis is the ratio between the apnea-hypopnea index (AHI) during REM and NREM sleep (the AHI-REM/AHI-NREM ratio), where an AHI-REM/AHI-NREM ratio ≥ 2 indicates a preponderance of respiratory events during REM sleep, or REM-related OSA.5 However, this definition is not accurate if REM sleep duration and NREM-AHI are not considered. Therefore, we need to use criteria that account for REM sleep duration and NREM-AHI.5

Blood pressure increases following obstructive events during REM and NREM sleep.6 However, REM sleep has been shown to be accompanied by enhanced sympathetic activity and instability of the cardiovascular system;6 therefore, theoretically, REM-related OSA may be related to more cardiovascular harmful events than NREM OSA. Recently, findings have pointed to an association between REM-related OSA and increased cardiovascular risk. A cross-sectional and longitudinal association between REM-related OSA and hypertension has been shown.7

A few studies have compared REM and NREM-OSA; however, previous studies either had a small sample size or did not apply strict criteria to define REM-related OSA. Additionally, racial differences in the prevalence of REM-related OSA have been reported,8 and no study has reported the prevalence of REM-related OSA in Saudi Arabs. Moreover, the relationship between menopausal status (using a precise definition) and REM-related OSA has not been well-explored. It has been shown that REM-related OSA is more common in women than men; however, it remains unclear whether REM-related OSA in women is related to age or premenopausal status.9 As REM-related OSA has been commonly reported in young men and women, this may basically indicate that REM-related OSA is related to a stiffer and younger airway, which is less likely to collapse during NREM sleep, rather than to menopausal status and female hormones.9 We hypothesized that REM-predominant OSA (REM-predominant OSA) in women is associated with a younger age rather than with menopausal status. Therefore, this study was designed to assess demographic characteristics, clinical features, comorbidities, and polysomnographic features of a large cohort of REM-predominant-OSA patients and compare these to non-stage-specific (NSS) OSA patients. Additionally, the study sought to assess the relation between REM-predominant OSA on one hand, and gender, age, and menopausal status on the other hand. As we used strict criteria to define REM-related OSA, we will call this REM-predominant OSA in this manuscript. Additionally, as obstructive events occur in both REM and NREM sleep, we will call OSA patients who do not meet the REM-predominant OSA diagnostic criteria, non-stage-specific OSA (NSS-OSA) patients.

Methods

In this prospective observational study, the data generated formed part of a project to assess REM-predominant OSA.5,6 In the period between January 2003 and December 2017, all patients (≥ 18-years-old) who consulted the University Sleep Disorders Centre (USDC) at King Saud University and were diagnosed with OSA based on nocturnal PSG were included. Diagnostic daytime sleep studies were excluded because the timing of REM sleep could be coupled to the circadian rhythm.10 Other exclusion criteria included sleeping less than 250 min and spending less than 15 min in REM sleep, as well as having received any previous surgical procedures for the treatment of snoring or OSA. In addition, patients with congestive heart failure, chronic neurological, muscular, or chronic obstructive pulmonary disease (COPD), wall and thoracic vertebral column deformities, daytime hypercapnia, and patients on sedative drugs were excluded. None of the included patients had been on positive airway pressure therapy or were using oral appliances at the time of recruitment.

All patients were clinically evaluated by a sleep medicine specialist to obtain a detailed medical history and physical examination. The information about comorbidities was acquired from patients’ medical histories and medical records. Postmenopausal status was defined when a patient was experiencing 12 consecutive months without menstruation.11,12 Subjective sleepiness was measured via the Epworth sleepiness scale (ESS).13

Figure 1 presents the study population flowchart.

Figure 1

Study population flow chart.

The study was approved by the Institutional Review Board of the Health Sciences Colleges Research on Human Subjects at King Saud University (E-19-4169). All participants signed a written informed consent form.

Polysomnography (Diagnostic Sleep Study)

All patients underwent standard PSG in accordance with the American Academy of Sleep Medicine (AASM) recommendations,14 with six leads for electroencephalography, electrooculography, electromyography for the chin and legs, electrocardiography, oxygen saturation (SPO2), thoracoabdominal movements, and airflow (thermistor and nasal pressure), using Alice® diagnostic equipment (Philips, Respironics Inc., Murrysville, PA, USA). Raw data were scored manually according to the AASM scoring criteria.14 Hypopneas scoring criteria included a decrement in nasal pressure signal by ≥50% for at least ≥10 seconds, followed by a ≥3% desaturation from the pre-event baseline or arousal. The desaturation index was computed as the number of desaturations (drop in oxygen saturation of ≥3%) divided by total sleep time expressed in hours. Obstructive apneas and hypopneas were calculated during REM and NREM sleep and expressed as REM-AHI and NREM-AHI.

REM-predominant OSA was defined as an obstructive AHI of ≥5, with a REM-AHI that was two times the NREM-AHI (REM-AHI/NREM-AHI of more than 2), an NREM-AHI of less than 15 events/h, and a minimum of 15 min of REM sleep.5 Patients with an obstructive AHI of more than 5 events/h but did not fulfill the criteria for REM-predominant OSA were considered as having a non-stage-specific OSA group (NSS).

Statistical Analysis

Data were analyzed using SPSS statistical software (version 24; Chicago, IL, USA). Mean and standard deviation (SD) were used to describe quantitative variables. For categorical variables, frequencies and percentages were used. For the two groups comparison, a Chi-square test was used for categorical variables and a Student’s t-test was used for normally distributed data. A Mann Whitney U-test was used for non-normally distributed data, based on the type of study and outcome variables.

To identify the independent correlates of REM-predominant OSA, a univariable logistic regression model was used initially where one explanatory factor was examined at a time. Next, explanatory factors with p-values less than 0.25 were entered into a multiple logistic regression model as per Hosmer-Lemeshow recommendations to identify the independent associations and correlates.

A p-value of <0.05 and a 95% confidence interval were used to report the statistical significance and precision of the results.

Results

The study comprised 1346 men and 823 women (total=2169). REM-predominant OSA was diagnosed in 17% (n=369), and NSS-OSA was diagnosed in 83% (n=1800). The mean age and BMI for women were 51.7 ± 12.9 years and 40.1 ± 11.9 kg/m2, respectively, and 43.7 ± 13.8 years and 33.6 ± 8.2 kg/m2 for men, respectively. The prevalence of REM-predominant OSA in women was 25% compared with 12% in men.

Table 1 presents the demographic characteristics and general information of the study groups. The mean age of patients with REM-predominant OSA was 43±14 years, compared with 47.5±13.9 years for those with NSS-OSA (P=<0.00). The percentage of women in the REM-predominant OSA group was significantly higher than that in NSS-OSA group (55% vs. 34.4%, p<0.01). However, there was no statistically significant difference between the REM-predominant OSA and NSS-OSA groups in terms of BMI. The mean ESS score was significantly lower in the REM-predominant OSA group compared to the NSS-OSA group (8.6±5.6 vs. NSS-OSA group 9.8±6.4; < 0.01).

Table 1

Demographics and General Information of Patients with REM-Predominant OSA and NSS-OSA

Variables*	Total n=2169	REM-Predominant OSA n=369 (17%)	NSS-OSA n=1800 (83%)	p-value
Age (Year)	46.7 ± 14	43 ± 14.1	47.5 ± 13.9	< 0.01
Sex (Female)	823 (37.9)	203 (55)	620 (34.4)	< 0.01
Body Mass Index (kg/m2)	36 ± 10.2	36.3 ± 9.7	35.9 ± 10.4	0.30
Neck circumference (inches)	15.5 ± 1.6	14.9 ± 1.5	15.6 ± 1.6	< 0.01
Waist circumference (cm)	44.5 ± 6.8	43 ± 6.5	44.7 ± 6.9	< 0.01
Epworth Sleepiness Scale	9.6 ± 6.2	8.6 ± 5.6	9.8 ± 6.4	< 0.01
Hemoglobin level (g/L)	113.2 ± 54.3	118.6 ± 46.7	112 ± 55.7	0.56
Hematocrit	42.4 ± 19.4	40.3 ± 5	42.9 ± 21.4	< 0.01
Fasting Blood Sugar	6.7 ± 3.6	6.1 ± 2.1	6.8 ± 3.9	0.09
FEV1/FVC (%)	85 ± 10.4	83.7 ± 7.8	85.2 ± 10.8	0.41
FVC (% predicted)	85.1 ± 24.4	85.4 ± 20.7	85 ± 25	0.10
FEV1 (% predicted)	87.3 ± 26	86.7 ± 21.7	87.4 ± 26.6	0.2
PSG OSA severity
Mild OSA	552 (25.5)	253 (68.5)	299 (16.6)	< 0.01
Moderate OSA	445 (20.5)	115 (31.2)	330 (18.3)
Severe OSA	1172 (54)	1 (0.3)	1171 (65.1)

Note: *Numerical data are expressed as mean ± standard deviation, and categorical data are expressed as n (%).

Abbreviations: REM, rapid eye movement; NSS, non-stage-specific; kg/m2, kilogram per squared meter; cm, centimeter; g/L, gram per liter; OSA, obstructive sleep apnea.

In the REM-predominant OSA group, OSA was classified as mild OSA in 253 (68.5%) of 368 patients, moderate in 115 (31.2%), and only one severe OSA case was identified. On the other hand, in the NSS-OSA group, mild OSA was found in 299 (16.6%), moderate OSA in 330 (18.3%), and severe OSA in 1171 (65.1%).

Women with REM-predominant OSA were significantly younger and tended to have a lower BMI compared to women with NSS-OSA (47.2 ± 13.2 years vs. 53.1 ± 12.5 years, p<0.01, and 38.6 ± 8.8 kg/m2 vs. 40.6 ± 12.7 kg/m2, p=0.06, respectively). For men, patients with REM-predominant OSA were significantly younger (37.8 ± 13.4 years vs. 44.6 ± 13.7 years, p < 0.01, respectively), but no difference in BMI was detected (33.6 ± 10 kg/m2 vs 33.6 ± 8 kg/m2, respectively).

Presenting Symptoms and Comorbidities

Table 2 shows the presenting symptoms and comorbidities in the studied groups. Nocturnal chest pain, awakening with a headache, and nocturnal awakening with palpitation were significantly more prevalent in the REM-predominant OSA group. However, snoring and witnessed apnea were more prevalent in the NSS-OSA group. Regarding comorbidities, insomnia, hypothyroidism, and bronchial asthma were more common among the REM-predominant OSA group, while hypertension and ischemic heart diseases were common among the NSS-OSA group.

Table 2

Symptoms and Comorbidities in Patients with REM-Predominant OSA and NSS-OSA

Variables*	Total n=2169	REM-Predominant OSA n=369 (17%)	NSS-OSA n=1800 (83%)	p-value
Presenting symptoms
Snoring	1431 (66)	203 (60.4)	1228 (73.5)	< 0.01
Witnessed apnea	1077 (49.7)	159 (47.3)	918 (55.3)	0.01
Nocturnal chest pain	555 (25.6)	110 (32.6)	445 (27)	0.04
Waking up with gastric acidity	683 (31.5)	120 (36.6)	563 (35.1)	0.62
Nocturnal choking	919 (42.4)	143 (42.4)	776 (46.9)	0.14
Awakening with headache	952 (43.9)	183 (54.3)	769 (46.5)	0.01
Nocturnal awakening with palpitation	633 (29.2)	130 (38.6)	503 (30.4)	< 0.01
Dry mouth on awakening	1291 (59.5)	200 (60.1)	1091 (67.1)	0.014
Nocturia	1267 (58.4)	201 (61.3)	1066 (66.8)	0.06
Comorbidities
Restless Legs Syndrome	44 (2)	10 (3.2)	34 (2.1)	0.26
Insomnia	52 (2.4)	16 (4.4)	36 (2)	0.01
Hypertension	837 (38.6)	110 (30.8)	727 (41.9)	< 0.01
Ischemic heart disease	123 (5.7)	9 (2.5)	114 (6.6)	< 0.01
Diabetes mellitus	636 (29.3)	103 (28.9)	533 (30.8)	0.48
Respiratory Failure	31 (1.4)	4 (1.1)	27 (1.6)	0.53
Compensated heart failure	30 (1.4)	2 (0.6)	28 (1.6)	0.13
Stroke	12 (0.6)	1 (0.3)	11 (0.6)	0.7
Bronchial asthma	491 (22.6)	106 (29.7)	385 (22.2)	< 0.01
Allergic rhinitis	228 (10.5)	33 (15.8)	195 (17.4)	0.57
Hypothyroidism	233 (10.7)	51 (14.2)	182 (10.4)	0.03
Hypercholesterolemia	629 (29)	109 (32.6)	520 (32.2)	0.87

Note: *Data are expressed as n (%).

Abbreviations: REM, rapid eye movement; NSS, non-stage-specific; OSA, obstructive sleep apnea.

Polysomnographic Findings

Table 3 shows the PSG parameters in both study groups. Sleep efficiency (total sleep time/time in bed) was also higher in REM-predominant OSA (84±95.2) than NSS-OSA (69.6 ±20.1). Stage N3, stage REM, the lowest recorded SpO2, and the mean nocturnal SpO2 (%) were higher in REM-predominant. The AHI was significantly lower in patients with REM-predominant OSA compared with the non-stage-specific OSA (12.2 ± 5.8 vs. 53.1 ± 34.5, p<0.01), as well as the time spent with SpO2 <90% (2.9 ± 10.6 min vs. 10.4 ± 20.8 min, respectively, p<0.01).

Table 3

Polysomnographic Findings in Patients REM-Predominant OSA and NSS-OSA

Variables*	Total n=2169	REM-Predominant OSA n=369 (17%)	NSS-OSA n=1800 (83%)	p-value
Sleep efficiency (%)	72.2 ± 44.6	84 ± 95.2	69.6 ± 20.1	< 0.01
Stage N1 (%)	10.9 ± 10.2	7.3 ± 8	11.7 ± 10.5	< 0.01
Stage N2 (%)	67.1 ± 14.9	63.4 ± 13.5	67.9 ± 15.1	< 0.01
Stage N3 (%)	4.3 ± 8.1	5.6 ± 7.9	4.1 ± 8.2	< 0.01
REM sleep duration (min)	27.3 ± 10.1	50.7 ± 15.9	23.5 ± 8.9	< 0.01
Stage REM (%)	12.3 ± 9.8	18.2 ± 7.2	11.1 ± 9.9	< 0.01
AHI (events/h)	46.2 ± 35.1	12.2 ± 5.8	53.1 ± 34.5	< 0.01
AHI-NREM (events/h)	44.4 ± 36.7	6.3 ± 3.9	52.2 ± 35.5	< 0.01
AHI-REM (events/h)	48.8 ± 34.1	39.8 ± 20	51.3 ± 36.7	< 0.01
Central apnea index (events/h)	1.3 ± 5.1	0.1 ± 1	1.6 ± 5.6	< 0.01
Obstructive apnea index (events/h)	6.6 ± 16.6	0.3 ± 0.8	8 ± 18	< 0.01
Mixed apnea index (events/h)	1.1 ± 5.5	0.01 ± 0.1	1.3 ± 6	< 0.01
Mean duration of the obstructive event during REM (sec)	19.1 ± 9.8	20.1 ± 7	18.9 ± 10.3	0.02
Mean duration of the obstructive event during NREM (sec)	19 ± 5.7	18 ± 5.1	19.2 ± 5.8	< 0.01
Desaturation Index (events/h)	25.9 ± 30.4	7 ± 7	29.8 ± 31.9	< 0.01
Time with SpO2 <90% (mins)	9.1 ± 19.7	2.9 ± 10.6	10.4 ± 20.8	< 0.01
Time with SpO2<95% (min)	44.8 ± 155.8	28.9 ± 33	48.1 ± 170.2	< 0.01
Lowest recorded SpO2 (%)	82.5 ± 11.3	86.3 ± 7.6	81.7 ± 11.8	< 0.01
Mean nocturnal SpO2 (%)	94.2 ± 5.2	95.3 ± 4.4	94 ± 5.3	< 0.01
Arousal Index (arousals/h)	48.9 ± 32	19.5 ± 9.4	54.9 ± 31.6	< 0.01
Periodic Leg Movement Index (events/h)	2 ± 2.2	1 ± 1.1	2.1 ± 2.3	< 0.01

Note: *Numerical data are expressed as mean ± standard deviation, and categorical data are expressed as n (%).

Abbreviations: REM, rapid eye movement; NREM, non-rapid eye movement; NSS, non-stage-specific; kg/m2, kilogram per squared meter; cm, centimeter; g/L, gram per liter; OSA, obstructive sleep apnea; AHI, apnea-hypopnea index; SpO2, arterial oxygen saturation; h, hour; min, minutes.

Correlates of REM-Predominant OSA

Table 4 presents the independent associations of REM-predominant OSA according to the univariable and multiple logistic regression analyses in the whole group. The multiple logistic regression model identified age (OR: 0.97 [0.95–0.98], p<0.01), female sex (OR: 6.95 [4.86–9.93], p>0.01), and the ESS (OR: 0.94 [0.92–0.97], < 0.01) as independent correlates of REM-predominant OSA, and sleep efficiency (OR: 1.04 [1.03–1.05], < 0.01), REM sleep duration (min) (OR: 1.02 [1.02–1.03], < 0.01), and time with SpO2 <90% (mins) (OR: 0.97 [0.95–0.99], < 0.01) as PSG parameters, and hypertension (OR:0.67 [0.45–0.99], 0.04) and bronchial asthma (OR: 2.19 [1.56–3.07], < 0.01) as comorbidities.

Table 4

The Independent Correlates of REM-Predominant OSA According to the Univariable and Multiple Logistic Regression (n=2169)

	Variables in the Equation	P-value	OR [95% C.I.]
Univariate model
	Age (Year)	< 0.01	0.98 [0.97–0.99]
	Body Mass Index (kg/m2)	0.49	1 [0.99–1.01]
	Sex (Female)	< 0.01	2.33 [1.86–2.92]
	Hypertension	< 0.01	0.62 [0.48–0.79]
	Diabetes mellitus	0.48	0.91 [0.71–1.17]
	Hypothyroidism	0.04	1.43 [1.03–2]
	Epworth Sleepiness Scale	< 0.01	0.97 [0.95–0.99]
	Postmenopausal	< 0.01	0.43 [0.31–0.59]
	Ischemic heart disease	< 0.01	0.37 [0.18–0.73]
	Bronchial Asthma	< 0.01	1.48 [1.15–1.9]
	Sleep Efficiency (%)	< 0.01	1.03 [1.02–1.03]
	Stage N1 (%)	< 0.01	0.94 [0.92–0.95]
	Stage N2 (%)	< 0.01	0.98 [0.97–0.99]
	Stage N3 (%)	0.02	1.02 [1.003–1.04]
	Stage REM (%)	< 0.01	1.08 [1.06–1.09]
	REM sleep duration (min)	< 0.01	1.03 [1.03–1.04]
	Apnea Hypopnea Index (events/hr)	< 0.01	0.86 [0.84–0.88]
	Desaturation Index (desaturations/hr)	< 0.01	0.92 [0.91–0.94]
	Time with SpO2 <90% (mins)	< 0.01	0.96 [0.94–0.97]
	Lowest Recorded SpO2 (%)	< 0.01	1.06 [1.04–1.07]
	Mean Nocturnal SpO2 (%)	< 0.01	1.16 [1.11–1.22]
Multiple logistic regression model**
	Age (Year)	< 0.01	0.97 [0.95–0.98]
	Sex (Female)	< 0.01	6.95 [4.86–9.93]
	Hypertension	0.04	0.67 [0.45–0.99]
	Epworth Sleepiness Scale	< 0.01	0.94 [0.92–0.97]
	Bronchial asthma	< 0.01	2.19 [1.56–3.07]
	Sleep efficiency (%)	< 0.01	1.04 [1.03–1.05]
	REM sleep duration (min)	< 0.01	1.02 [1.02–1.03]
	Time with SpO2 <90% (mins)	< 0.01	0.97 [0.95–0.99]

Notes: **Multicollinearity: None. Overall accuracy: 96.7%, Sensitivity: 88.6%, Specificity: 98.1%, Area under the Curve (ROC): 99.3%, Omnibus Tests of Model: p<0.001, Hosmer-Lemeshow goodness of fit: p=0.998, Nagelkerke R Square: 89.5%.

Abbreviations: REM, rapid eye movement; OSA, obstructive sleep apnea; SpO2, arterial oxygen saturation; h, hour; min, minutes.

Gender and REM-Predominant OSA

Women were divided into a premenopausal (n=307) and postmenopausal (n=516) group. The prevalence of REM-predominant OSA in premenopausal and postmenopausal women was 35% and 18.6% (p< 0.01), respectively.

Table 5 presents a comparison between the demographic characteristics, comorbidities, and PSG findings in REM-predominant OSA and non-stage-specific OSA groups categorized by sex. Patients with REM-predominant OSA were younger and had less snoring across both genders. The ESS score in women with REM-predominant OSA was lower than that in the NSS-OSA group (7.6 ± 5.1 vs.9.4 ± 5.7, p< 0.001, respectively). Hypertension was more prevalent in the NSS-OSA group in both women and men compared to the REM-predominant OSA group.

Table 5

A Comparison Between the Demographics, Comorbidities, and PSG Findings in Patients with REM-Predominant OSA and Non-Stage-Specific OSA Groups Categorized by Sex

Variables*	Women		P-value	Men		P-value	REM-Predominant OSA		P-value
	REM-Predominant OSA (n=203)	NSS-OSA (n= 620)		REM-Predominant OSA (n=166)	NSS-OSA (n= 1180)		Women (n=203)	Men (n=166)
Demographics and general information
Age (Year)	47.2 ± 13.2	53.1 ± 12.5	< 0.01	37.8 ± 13.4	44.6 ± 13.7	< 0.01	47.2 ± 13.2	37.8 ± 13.4	< 0.01
Body Mass Index (kg/m2)	38.6 ± 8.8	40.6 ± 12.7	0.06	33.6 ± 10	33.6 ± 8	0.20	38.6 ± 8.8	33.6 ± 10	< 0.01
Epworth Sleepiness Scale	7.6 ± 5.1	9.4 ± 5.7	< 0.01	9.8 ± 5.9	10 ± 6.7	0.94	7.6 ± 5.1	9.8 ± 5.9	< 0.01
Postmenopausal	96 (47.3)	420 (67.7)	< 0.01	-	-	-	96 (47.3)	-	-
Snoring	109 (59.9)	415 (70.7)	0.01	94 (61)	813 (75)	< 0.01	109 (59.9)	94 (61)	0.83
Witnessed apnea	82 (44.8)	310 (53)	0.05	77 (50.3)	608 (56.6)	0.15	82 (44.8)	77 (50.3)	0.31
Comorbidities
Hypertension	81 (41.1)	364 (60.7)	< 0.01	29 (18.1)	363 (32)	< 0.01	81 (41.1)	29 (18.1)	< 0.01
Ischemic heart disease	8 (4.1)	54 (9)	0.03	1 (0.6)	60 (5.3)	0.01	8 (4.1)	1 (0.6)	0.04
Diabetes mellitus	73 (37.2)	268 (44.9)	0.06	30 (18.6)	265 (23.3)	0.18	73 (37.2)	30 (18.6)	< 0.01
Bronchial asthma	68 (34.5)	201 (33.6)	0.82	38 (23.8)	184 (16.2)	0.02	68 (34.5)	38 (23.8)	0.03
Hypothyroidism	47 (23.9)	128 (21.1)	0.42	4 (2.5)	54 (4.7)	0.20	47 (23.9)	4 (2.5)	< 0.01
Hypercholesterolemia	73 (39.9)	241 (42.7)	0.50	36 (23.8)	279 (26.5)	0.48	73 (39.9)	36 (23.8)	< 0.01
Polysomnographic findings
Sleep Efficiency (%)	85.5 ± 127.8	64 ± 20.5	< 0.01	82.2 ± 13.8	72.6 ± 19.3	< 0.01	85.5 ± 127.8	82.2 ± 13.8	< 0.01
Stage N1 (%)	7.8 ± 6.9	12.3 ± 11.4	< 0.01	6.8 ± 9.2	11.4 ± 9.9	< 0.01	7.8 ± 6.9	6.8 ± 9.2	0.01
Stage N2 (%)	64.2 ± 13.5	67.2 ± 16	0.01	62.5 ± 13.5	68.3 ± 14.6	< 0.01	64.2 ± 13.5	62.5 ± 13.5	0.26
Stage N3 (%)	4.7 ± 7.4	4.4 ± 9.2	0.24	6.7 ± 8.4	3.9 ± 7.6	< 0.01	4.7 ± 7.4	6.7 ± 8.4	0.03
Stage REM (%)	17.1 ± 7	10.3 ± 9.9	< 0.01	19.5 ± 7.2	11.6 ± 9.8	< 0.01	17.1 ± 7	19.5 ± 7.2	< 0.01
AHI	12 ± 6	51.4 ± 34.6	< 0.01	12.4 ± 5.5	54.1 ± 34.4	< 0.01	12 ± 6	12.4 ± 5.5	0.27
Desaturation Index (desaturations/hr.)	7.2 ± 7.3	27.7 ± 30.3	< 0.01	6.7 ± 6.7	30.9 ± 32.6	< 0.01	7.2 ± 7.3	6.7 ± 6.7	0.30
Time with SpO2 <90% (min)	3.6 ± 12.5	11.3 ± 22.1	< 0.01	2 ± 7.6	10 ± 20.1	< 0.01	3.6 ± 12.5	2 ± 7.6	0.22
Lowest Recorded SpO2 (%)	85.9 ± 7.6	81.5 ± 12.5	< 0.01	86.8 ± 7.7	81.8 ± 11.4	< 0.01	85.9 ± 7.6	86.8 ± 7.7	0.14
Mean Nocturnal SpO2 (%)	95.3 ± 5.8	94.2 ± 5.1	< 0.01	95.3 ± 1.6	93.9 ± 5.4	< 0.01	95.3 ± 5.8	95.3 ± 1.6	0.01

Notes: *Numerical data are expressed as mean ± standard deviation, and categorical data are expressed as n (%).

Abbreviations: REM, rapid eye movement; OSA, obstructive sleep apnea; SpO2, arterial oxygen saturation; h, hour; min, minutes; kg/m2, kilogram per squared meter.

In addition, Table 5 presents a comparison between women and men with REM-predominant OSA. Women with REM-predominant OSA were older, heavier, and had a significantly lower ESS score. Additionally, the prevalence of hypertension, diabetes mellitus, ischemic heart disease, bronchial asthma, hypothyroidism, and hypercholesterolemia was significantly higher among women with REM-predominant OSA.

To assess the impact of age and menopausal status in women, a logistic regression analysis was carried out. Table 6 presents the univariable and multiple logistic regression analyses for the correlates of REM-predominant OSA in women. Age was an independent correlate (OR: 0.97 [0.94–0.99], p=0.03); however, menopausal status was not an independent correlate in the model. Other correlates of REM-predominant OSA in women were body mass index, hypertension, hypothyroidism, the Epworth sleepiness scale, stage N1 (%), REM sleep duration, and time with SpO2 <90%.

Table 6

The Independent Correlates of REM-Predominant OSA According to the Univariable and Multiple Logistic Regression in Men and Women

Men	Variables in the Equation	P-value	OR [95% C.I.]	Women	Variables in the Equation	P-value	OR [95% C.I.]
Univariable model				Univariable model
	Age (Year)	< 0.01	0.96 [0.95–0.98]		Age (Year)	< 0.01	0.97 [0.95–0.98]
	Body Mass Index (kg/m2)	0.99	1 [0.98–1.02]		Body Mass Index (kg/m2)	0.03	0.98 [0.97–0.99]
	Hypertension	< 0.01	0.47 [0.31–0.72]		Hypertension	< 0.01	0.45 [0.33–0.63]
	Diabetes mellitus	0.20	0.75 [0.49–1.15]		Diabetes mellitus	0.06	0.73 [0.52–1.01]
	Hypothyroidism	0.21	0.51 [0.18–1.44]		Hypothyroidism	0.42	1.17 [0.8–1.71]
	Epworth Sleepiness Scale	0.71	1 [0.97–1.02]		Epworth Sleepiness Scale	< 0.01	0.94 [0.91–0.97]
	Ischemic heart disease	0.03	0.11 [0.02–0.81]		Ischemic heart disease	0.03	0.43 [0.2–0.92]
	Bronchial Asthma	0.02	1.61 [1.08–2.39]		Bronchial Asthma	0.82	1.04 [0.74–1.46]
	Sleep Efficiency (%)	< 0.01	1.04 [1.02–1.05]		Sleep Efficiency (%)	< 0.01	1.03 [1.02–1.04]
	Stage N1 (%)	< 0.01	0.92 [0.90–0.95]		Stage N1 (%)	< 0.01	0.94 [0.92–0.96]
	Stage N2 (%)	< 0.01	0.97 [0.96–0.99]		Stage N2 (%)	0.02	0.99 [0.98–0.99]
	Stage N3 (%)	< 0.01	1.04 [1.01–1.06]		Stage N3 (%)	0.81	1 [0.98–1.03]
	Stage REM (%)	< 0.01	1.08 [1.06–1.10]		Stage REM (%)	< 0.01	1.08 [1.06–1.1]
	REM sleep duration (min)	< 0.01	1.03 [1.03–1.04]		REM sleep duration (min)	< 0.01	1.04 [1.03–1.05]
	AHI (events/h)	< 0.01	0.87 [0.85–0.89]		AHI (events/h)	< 0.01	0.86 [0.83–0.88]
	Desaturation Index (desaturations/h)	< 0.01	0.92 [0.90–0.94]		Desaturation Index (desaturations/h)	< 0.01	0.93 [0.91–0.94]
	Time with SpO2 <90% (min)	< 0.01	0.93 [0.91–0.96]		Time with SpO2 <90% (min)	< 0.01	0.97 [0.95–0.98]
	Lowest Recorded SpO2 (%)	< 0.01	1.07 [1.04–1.10]		Lowest Recorded SpO2 (%)	< 0.01	1.05 [1.03–1.07]
	Mean Nocturnal SpO2 (%)	< 0.01	1.24 [1.13–1.35]		Mean Nocturnal SpO2 (%)	< 0.01	1.09 [1.03–1.16]
					Premenopausal	< 0.01	0.43 [0.31–0.59]
Multiple logistic regression model*				Multiple logistic regression model**
	Age (Year)	0.02	0.95 [0.91–0.99]		Age (Year)	0.03	0.97 [0.94–0.99]
	Hypertension	0.01	7.82 [1.81–33.87]		Body Mass Index (kg/m2)	0.01	1.02 [1.01–1.04]
	Bronchial asthma	< 0.01	6.26 [2.02–19.44]		Hypertension	0.05	0.53 [0.29–0.99]
	Sleep efficiency (%)	0.03	1.05 [1.01–1.1]		Hypothyroidism	< 0.01	2.29 [1.3–4.05]
	Stage N1 (%)	0.01	0.94 [0.89–0.99]		Epworth Sleepiness Scale	< 0.01	0.89 [0.85–0.93]
	Lowest Recorded SpO2 (%)	< 0.01	0.88 [0.81–0.96]		Stage N1 (%)	< 0.01	0.89 [0.84–0.94]
	AHI (events/h)	< 0.01	0.75 [0.69–0.82]		REM Duration	< 0.01	1.07 [1.06–1.09]
					Time with SpO2 <90% (min)	0.03	0.97 [0.95–1]

Notes: *Multicollinearity: None. Overall accuracy: 97.7%, Sensitivity: 85.1%, Specificity: 98.8%, Area under the Curve (ROC): 99.7%, Omnibus Tests of Model: p<0.01, Hosmer-Lemeshow goodness of fit: p=1.00, Nagelkerke R Square: 89.6%. **Multicollinearity: None. Overall accuracy: 83.7%, Sensitivity: 55.2%, Specificity: 92.4%, Area under the Curve (ROC): 91.4%, Omnibus Tests of Model: p<0.01, Hosmer-Lemeshow goodness of fit: p= 0.02, Nagelkerke R Square: 55.5%.

Abbreviations: AHI, apnea-hypopnea index; REM, rapid eye movement; OSA, obstructive sleep apnea; SpO2, arterial oxygen saturation; h, hour; min, minutes; kg/m2, kilogram per squared meter.

Among men (Table 6), the following independent correlates of REM-predominant OSA were identified: age, Hypertension, bronchial asthma, sleep efficiency, stage N1 (%), lowest recorded SpO2, and AHI.

Discussion

This large clinic-based study used criteria based on AHI, REM-AHI/NREM-AHI ratio, and REM sleep duration to define REM-predominant OSA. With these strict criteria, REM-predominant OSA was prevalent among patients with OSA in a sleep clinic setting occurring in 17% of the studied sample. Additionally, this is the first study to assess the relationship between female sex and menopausal status with REM-predominant OSA using a clear definition for postmenopausal status. The central finding of this study is that age rather than menopausal status was an independent correlate of REM-predominant OSA in women, thereby supporting our hypothesis.

Determining the exact prevalence of REM-predominant OSA requires a clear definition and diagnostic criteria for this disorder. However, at present, there is no consensus among experts on a definition of REM-related OSA. Previous studies have reported variable prevalences, ranging from 2.7–62%.4,7–9,15–21 Table 7 presents a summary of previous clinic-based and community-based studies that have reported the prevalence of REM-OSA. In an earlier study, O’Conner et al used a definition that comprised patients with a total AHI ranging from 5/h to 25/h, an NREM-AHI < 15/h and REM-AHI/NREM-AHI of over 2, and a reported a prevalence of REM-OSA of 62% among women and 24% among men.18 Diagnosing patients with REM-related OSA based on the REM-AHI/NREM-AHI ratio is not accurate because it will label some patients as having REM-related OSA, even when there are coexisting significant obstructive events during NREM sleep.22 For example, if a patient has a total REM-AHI of 90 events/h and an NREM-AHI of 30 events/h, the ratio will be more than two, and he will be diagnosed with REM-related OSA, when, in fact, he also has severe NREM-OSA. Another cross-sectional study of 45 obese subjects accounted for the AHI in NREM sleep and used the following criteria to diagnose REM-related OSA: a total AHI between 5/h and 25/h, an NREM-AHI < 15/h, and REM-AHI/NREM AHI > 2.19 Results showed that REM-OSA was diagnosed in 4% of men and 35% of women.19 However, not including a minimum duration for REM sleep is insufficient to diagnose REM-related OSA. For example, if a patient spent one minute in REM sleep and had one obstructive event during REM sleep, the REM-AHI will be 60 events/h, which can be misleading. This concept is reflected by Conwell et al’s study, which assessed the impact of three different diagnostic criteria on the prevalence of REM-OSA.8 The prevalence of REM-related OSA was 37% using a total AHI≥5 and AHI-REM/AHI-NREM≥2, 24.4% using a total AHI≥5, AHI-REM/AHI-NREM≥2, and AHI-NREM<15, and 13.5% using a total AHI≥5, AHI-REM/AHI-NREM≥2, AHI-NREM<8, and at least 10.5 min of REM sleep.8 Similar findings were reported by Mano et al in a recent Japanese study.21

Table 7

A Summary of the Studies That Assessed the Prevalence of REM-OSA in the Sleep Laboratory Setting and the Community

Authors	Study design	Age & BMI	REM-OSA Definition	Findings
Clinic-based studies
O’Connor et al 200018	A retrospective study of 830 patients with OSA diagnosed by overnight PSG	Age: Women 50.8±0.9Men: 48.6±0.5BMI: 35.1±0.632.1 ± 0.3	Total AHI between 5/h and 25/h, an NREM AHI < 15/h, and REM AHI/NREM AHI > 2	REM-OSA was diagnosed in 24% of 632 men and 62% of 206 womenwith PSG-identified OSA
Koo et al 200817	2486 patients referred to a sleep laboratory	Age: 50.8 ± 0.3 BMI: 30.8 ± 0.1	NREM-AHI ≤15/h and REM-AHI/NREM-AHI ratio ≥2	21% of men and 40.8% of women had REM-OSAFemale sex remained an independent predictor of REM-OSA (OR, 3.0). REM-OSA prevalence decreased with increasing age in both sexes
Resta et al 200519	A cross-sectional study of 45 obese subjects, 20 females and 25 males	Age:Men 45±10 Women 43±13.5BMI:Men: 40±10. Women:39.7±7	Total AHI between 5/h and 25/h,an NREM-AHI < 15/h, and REM-AHI/NREM AHI > 2	REM-OSA was diagnosed in 4% of men and 35% of women
Haba-Rubio et al 20054	A cross-sectional study of 415 patients with OSA	Age; 53±11.6	An AHI-REM/AHI-NREM ratio >2.	REM-OSA was diagnosed in 36% ofOSA patients
Koo et al 20089	A retrospective study of 1540 OSA patients.	Age: 50±0.8BMI: 35.7±0.7	NREM-AHI < 15, and REM-AHI/NREM-AHI > 2	REM-OSA was diagnosed in 14.4% of patients
Conwell et al 20128	A cross-section study of patients referred to a sleep laboratory (n=931)	Age: 45±15BMI: 36±9	Three definitions:1. Overall AHI≥5 and AHI-REM/AHI-NREM≥22. Overall AHI≥5, AHI-REM/AHI-NREM≥2, and AHI-NREM<153. Overall AHI≥5, AHI-REM/AHI-NREM≥2, AHI-NREM<8, and at least 10.5 min of REM sleep duration	1. REM-OSA was diagnosed in 37% when only REM-AHI/NREM-AHI 2 was used,2. 24.4% when the criterion of NREMAHI < 15/h was added,3. 13.5% when the criterion ofNREM AHI < 8/h and at least at least 10.5 min of REM sleep duration were added
Mano et al 201921	A total of 3234 Japanese patients with OSA	Age:Women: 57.1 ± 13.8Men: 51.7 ± 13.5BMI:Women: 27.2 ± 7.9Men: 26.9 ± 5.0	Three definitions: Total AHI>5 and REM-AHI/NREM-AHI>2; AHI>5 and REM-AHI/NREM-AHI>2, and NREM-AHI<15; AHI>5 and REM-AHI/NREM-AHI>2, and NREM-AHI<8, and REM sleep > 10.5 min	The prevalence in women and men according to diagnostic criteria #1, #2, and #3 were 47.7 vs. 19%, 37.5% vs. 14.5%, and 26.3% vs. 8.7%, respectively.
Al Oweidat et al.201820	A cross-sectional study of 478 patients	Age: 55.3±12.6BMI: 36.6±7.6	Two criteria AHI-REM/AHI-NREM at least 2. AHI-REM ≥ 5 and AHI-NREM < 5, with a total REM sleep of ≥ 30 min.	REM-OSA prevalence:Criteria #1: 18%Criteria #2: 2.7%
Current study Bahammam et al 2020	Prospectively collected data on 2169 OSA patients		Obstructive AHI of ≥5, with REM-AHI/NREM-AHI of >2, an NREM-AHI of <15, and a minimum of 15 min of REM sleep	REM-predominant OSA was diagnosed in 17%. The prevalence of REM-predominant OSA in women and men was 25% and 12%, respectively
Community-based epidemiological data
Mokhlesi et al 20147	The longitudinal community-based Wisconsin Sleep Cohort Study (n=4385 sleep studies on 1451 individuals)	Age: 54 ± 10BMI: 30 ± 6	30 min of REM and an NREM AHI (4%) ≤ 5 events/h	12% demonstrated a REM-AHI ≥15 events/hAmong studies where the totalAHI was < 15 events/h, 22% demonstrated a REM-AHI ≥ 15 events/h.
Aurora et al 201815	The Sleep Heart Health Study (n= 3265)	Age: 62±10.7BMI: 27.8±5	At least 30 min of REM sleep and an NREM AHI4%< 5 events/h	27.7% had a REM-AHI of 5.0–14.9 events/h, 13% had a REM-AHI of 15.0–29.9 events/h, and 5.5% had a REM-AHI > 30 events/h
Khan et al 201316	A cross-sectional analysis of 2765 Older Men, the (MrOS Sleep) Study	Age: 76BMI: 25–29	OSA was defined as AHI ≥ 15 during the entire sleep period. REM-predominant OSA was defined as AHI < 15, but REM-AHI ≥ 5	REM-predominant OSA (AHI-REM ≥ 5) was 42.8% if OSA was defined as AHI ≥ 15 and 14.4% if OSA was defined as AHI ≥ 5.

Abbreviations: REM, rapid eye movement; NREM, non-rapid eye movement; BMI, body mass index; AHI, apnea-hypopnea index.

Moreover, the diagnostic definition used of hypopnea affects the reported prevalence of REM-related OSA. Using the 2012 “3% desaturation and/or arousal” detects a lower percentage of REM-related OSA cases compared with the 2007 “4% desaturation criteria”, as it may decrease the REM-AHI/NREM-AHI ratio.23 In the current paper, we used conservative criteria that applied the REM-AHI/NREM-AHI ratio, the 2012 diagnostic criteria of hypopnea, NREM-AHI<15, and minimum sleep duration. Nevertheless, despite variations in the used definitions of REM-related OSA, the current study and previous community-based and clinic population studies demonstrated that REM-related OSA is prevalent.

In the current study, the prevalence of REM-predominant OSA in women was double that in men, and female sex was an independent correlate of REM-predominant OSA. This finding is consistent with previous studies that assessed gender differences in OSA and reported a clustering of respiratory events during REM sleep in women, compared with men who had mainly NREM obstructive events.9,21,24,25 Additionally, patients with REM-predominant OSA were younger, which raises the question of whether age or menopausal status is the culprit in women. Therefore, we assessed the independent correlates of REM-predominant OSA among women. Menopausal status and age were correlates in the univariable analysis model; however, in the multiple logistic regression model, only age remained as an independent correlate of REM-predominant OSA. A recent study demonstrated that REM-related OSA is more common in women, irrespective of menopausal status (crudely defined by age >50 years).21 This is consistent with our findings, which demonstrated that age and female sex are independent correlates, but not menopausal status.

It has also been proposed that female hormones (estrogen and progesterone) may protect women against OSA by increasing the tonicity of the upper airway muscles and stimulating ventilation.26 However, it is possible that the hormonal protective effects may not protect women against airway closure during REM sleep. This could be related to the atonia that accompanies REM sleep, which requires more research to elucidate this relationship. In addition, sex affects the pharyngeal area;26 therefore, it is possible that the pharyngeal wall in women is more prone to collapse during REM sleep due to its smaller size. Moreover, as obesity was more prevalent among patients with REM-predominant OSA, it is possible that obesity may have a higher impact on the upper airway of women during REM sleep due to its smaller size.9

In the current study, the ESS was lower in REM-predominant OSA than in NSS-OSA and was independently associated with REM-predominant OSA after adjusting for demographics, BMI, and PSG parameters. Although sleepiness usually correlates with OSA severity,27 studies that assessed patients with REM-related OSA reported less association with daytime sleepiness.27–29 However, there is no consistency on data related to sleepiness in REM-related OSA; a clinic-based study of 1821 subjects who underwent both PSG and multiple sleep latency reported that after adjusting for age, sex, BMI, and the duration of NREM and REM sleep, the REM-related OSA severity was not associated with daytime sleepiness.29 Similarly, in the Sleep Heart Health Study, REM-related OSA was not associated with daytime sleepiness measured by the ESS after adjusting for demographics, BMI, and NREM-AHI.28

Insomnia was also more common in patients with REM-predominant OSA than in patients with NSS-OSA. A recent study reported the Pittsburgh Sleep Quality Index (PSQI) scores in 1736 patients with OSA; REM-related OSA was significantly associated with an increased PSQI score.30 Snoring was less common among patients with REM-predominant OSA (OR: 0.67, CI: 0.512–0.896). This could be related to the intensity of snoring during different sleep stages. It has been shown that the intensity of snoring was greater during NREM sleep, particularly in stage N3, and less pronounced in REM sleep.31,32 Additionally, REM-predominant OSA was more prevalent among women, and it is known that snoring intensity (dB) is commonly higher in men compared to women,33 and, further, that it correlates with AHI, which is lower during REM-predominant OSA.31,33

Interestingly, hypertension and a history of ischemic heart disease were more common in NSS-OSA. This can be partially explained by the fact that the NSS-OSA group was older and had a higher BMI. Therefore, the current results should not be mistakenly interpreted that REM-predominant OSA has a lower risk of cardiac morbidity, as community-based studies have suggested that REM-related OSA is significantly associated with hypertension, independent of NREM-OSA.7,34,35 Moreover, the NSS-OSA group had a high REM-AHI of 51.3 ± 36.7/h; however, the ratio of REM-AHI-NREN-AHI was less than 2.

Another interesting finding is the fact that bronchial asthma was an independent correlate of REM-predominant OSA. Recent data have indicated a strong link between bronchial asthma and OSA, while showing a bidirectional relationship between the two disorders.36 An earlier study has demonstrated that adults with stable asthma have a cluster of irregular breathing and hypoxemia during REM sleep.37 Studies in mice revealed that REM sleep is associated with increasing cholinergic outflow and wear-down of noradrenergic signals in the brainstem, which are relevant controllers of the lower airways’ caliber and reactivity.38 In an earlier study, Shapiro et al assessed the relationship between bronchoconstriction and sleep stages.39 The investigators performed forced expiratory maneuvers, directly after being awakened from REM or NREM sleep, on eight patients with asthma and eight controls. After patients with asthma were awakened from REM sleep, the forced expiratory volume in one second (FEV1) and peak expiratory flow (PEF) rate were significantly lower than after they had been awakened from NREM sleep.39 A subsequent multiple logistic regression analysis was performed to account for possible temporal effects from those related to the stage of sleep, demonstrating that the overnight decrement in FEV1 and PEF rate were significantly related to REM sleep.39 Recent studies in children revealed that REM-related OSA is significantly increased in children with OSA and comorbid asthma compared to children with OSA alone and that the association between asthma and REM-related OSA was independent of asthma control, BMI, age, and sex.40,41 Therefore, it seems that there is an association between asthma and REM-related OSA. Further research is warranted to explain the REM sleep neurobiological mechanisms that potentially influence OSA expression in patients with asthma.

The current study has strengths and limitations. Strengths include having clear inclusion and exclusion criteria and using strict criteria to define REM-predominant OSA, including a cut-off point for NREM-AHI, REM-AHI/NREM-AHI ratio, and minimum duration for REM sleep. The large sample size represents another strength. Additionally, this is the first study to assess the association between REM-related OSA and menopausal status using a clear definition of menopause.

Limitation includes the fact that the study was conducted in a single center. Additionally, being a clinic-based study means that there could be a selection bias, as symptomatic patients are usually referred to the clinic.

Conclusion

The current study demonstrated that REM-predominant OSA, using strict criteria to define it, is prevalent among clinic-based patients with OSA. Younger age and female sex were among the independent associations of REM-predominant OSA. Among women, a younger age but not menopausal status was an independent correlate of REM-predominant OSA. Interestingly, bronchial asthma was independently associated with REM-predominant OSA, supporting previous experimental data suggesting an association between asthma and REM-related OSA.